Initial U.S. jobless claims jumped 34,000 to 406,000 for the week ended July 19, the U.S. Labor Department announced Thursday. Claims for the previous week were revised to 372,000. Further, this week's 406,000 statistic was the highest weekly jobless claims tally since March.
Economists surveyed by Bloomberg News had expected this week's initial jobless claims to total 375,000.
Also, the 4-week moving average increased 4,500 to 382,500. Economists view the 4-week average as a better indicator of unemployment conditions, as it smooths-out anomalies for strikes, holidays, or other idiosyncratic events.
Economist Peter Dawson said "job loss statistics continue to reveal an economy that's barely growing, with no job growth, save a few sectors."
The largest increases in initial claims for the week ending July 12 were in: New York, +13,909, California, +9,416, North Carolina, +9,344, Tennessee, +8,522, and Georgia, +7,000. The largest decreases were in: Michigan, -4,571, New Jersey, -1,835, Kentucky, -1,724, Rhode Island, -1,266, and Massachusetts, -919.
Meanwhile, the number of continuing claims decreased 9,000 to 3.107 million from a revised 3.116 million for the week ended July 12, the latest period for which figures were available.
Economic Analysis: A worse-than-expected weekly jobless claims report. While the 4-week moving average dropped to 382,500, it is still an elevated rate, indicative of soft labor market conditions.
Last updated: February 09, 2012: 04:33 PM
Hot Stocks
DailyFinance Headlines
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
- Readers' Tips for Financial Renewal, Part 4: Get the Right Job
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Tesla Motors February put volatility elevated into unveiling of Model X
- Manulife Financial reportedly establishing 'high net worth' unit, DJ says
- Linkedin February weekly 75 straddle priced for 11% move into Q4
- P.A.M. Transportation reports Q4 EPS 2c vs. consensus (12c)
- Tesla Motors teases Model X event on corporate website
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
- Readers' Tips for Financial Renewal, Part 4: Get the Right Job
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

